Hydroxycut Consumers Reach $25M Deal In False Ad MDL

Law360, New York (November 5, 2012, 1:57 PM EST) -- Class action plaintiffs in false marketing multidistrict litigation over recalled dietary supplement Hydroxycut products asked a California federal judge Friday to approve a $25.3 million settlement that would resolve the class actions but not individual personal injury suits that are also part of the MDL.

The plaintiffs alleged that Kerr Investment Holding Corp., the parent corporation for Hydroxycut maker Iovate Health Sciences Inc., and certain retailers including Wal-Mart Stores Inc. and Vitamin Shoppe Industries Inc. marketed Hydroxycut-branded products as safe and effective treatments for weight loss...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.